富含的纳米波剂通过铁灭亡介导的免疫激活和STING通路协同作用来增强BNCT的疗效
Zhicheng Zhang1,2, Xiaoyan Sun2, Yaxin Qin2,3
1Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310058, China.
Journal of nanobiotechnology
|December 20, 2025
概括
中子捕获疗法 (BNCT) 通过一种新的纳米剂来增强,可以增强抗瘤免疫力和MRI指导. 这种方法克服了BNCT.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 中子捕获疗法 (BNCT) 选择性地消去瘤细胞,但受到免疫抑制和高瘤内H2O2水平的限制,阻碍了免疫疗法协同作用.
- 现有的BNCT策略在克服瘤微环境的抑制作用和整合诊断能力方面面临挑战.
研究的目的:
- 通过增强瘤微环境反应和免疫激活来克服BNCT的局限性,开发一种新的纳米子剂BSA-BPA-MnO2.
- 研究这个纳米平台与BNCT的协同潜力,以改善癌症治疗,特别是针对黑色素瘤.
主要方法:
- 开发一种对瘤微环境有反应的富含的纳米剂 (BSA-BPA-MnO2).
- 评估纳米平台提供的能力,催化芬顿类反应,并激活cGAS-STING通路.
- 评估BNCT诱导的氧化应激,热,I型干扰素信号传递和免疫细胞反应 (树突细胞,CD8+ T细胞).
- 整合MRI指导用于诊断和治疗能力.
主要成果:
- BSA-BPA-MnO2纳米平台放大了BNCT诱导的氧化应激,并触发了免疫性热和I型干扰素信号.
- 这种双重机制将BNCT转化为全身免疫激活剂,促进树突细胞成熟和CD8+ T细胞反应.
- 该平台表现出强大的瘤抑制和全身免疫激活,即使在亚临床度下,具有MRI指导能力.
结论:
- BSA-BPA-MnO2代表了下一代免疫综合性BNCT的有希望的策略,将局部疗法转化为全身免疫激活剂.
- 这种方法具有巨大的潜力,可以通过克服免疫抑制和提高治疗效率来治疗具有挑战性的癌症,如黑色素瘤.
- 在一个平台上集成诊断 (MRI) 和治疗,为癌症治疗模式提供了重大进步.
更多相关视频
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
6.1K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.5K
相关概念视频
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
